A Newly Discovered Drug Resistance Gene rfaF In Helicobacter pylori

References

• Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2(1):28–37. doi:10.1038/nrc70311902583
   PubMed Web of Science ®Google Scholar
• Delaney BC, Paul M, David F. Helicobacter pylori infection. N Engl J Med. 2005;2007(15):518–534.
   Google Scholar
• Garza-González E, Perez-Perez G, Maldonado-Garza H, et al. A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. World J Gastroenterol. 2014;20(6):1438–1449. doi:10.3748/wjg.v20.i6.143824587620
   PubMed Web of Science ®Google Scholar
• Goderska K, Pena SA, Alarcon T. Helicobacter pylori treatment: antibiotics or probiotics. Appl Microbiol Biotechnol. 2018;102(1):1–7. doi:10.1007/s00253-017-8535-729075827
   PubMed Web of Science ®Google Scholar
• Song Z, Zhou L, Zhang J, He L, Bai P, Xue Y. Hybrid therapy as first-line regimen for Helicobacter pylori eradication in populations with high antibiotic resistance rates. Helicobacter. 2016;21(5):382–388. doi:10.1111/hel.2016.21.issue-526809022
   PubMed Web of Science ®Google Scholar
• Hashemi SJ, Sheikh A, Goodarzi H, et al. Genetic basis for metronidazole and clarithromycin resistance in Helicobacter pylori strains isolated from patients with gastroduodenal disorders. Infect Drug Resist. 2019;12:535–543. doi:10.2147/IDR.S19294230881059
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang M, Lu B, Dai J. Helicobacter pylori and antibiotic resistance, a continuing and intractable problem. Helicobacter. 2016;21(5):349–363. doi:10.1111/hel.2016.21.issue-526822340
   PubMed Web of Science ®Google Scholar
• Chiu HC, Lin TL, Yang JC, Wang JT. Synergistic effect of imp/ostA and msbA in hydrophobic drug resistance of Helicobacter pylori. BMC Microbiol. 2009;9(1):136. doi:10.1186/1471-2180-9-13619594901
   PubMed Web of Science ®Google Scholar
• Co EMA, Schiller NL. Resistance mechanisms in an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Antimicrob Agents Chemother. 2006;50(12):4174–4176. doi:10.1128/AAC.00759-0617000747
   PubMed Web of Science ®Google Scholar
• Wu JY, Kim JJ, Rita R, Wang WM, Graham DY, Kwon DH. Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob Agents Chemother. 2005;49(2):578–583. doi:10.1128/AAC.49.2.578-583.200515673736
   PubMed Web of Science ®Google Scholar
• Allen AG, Isobe T, Maskell DJ. Identification and cloning of waaF (rfaF) from Bordetella pertussis and use to generate mutants of Bordetella spp. with deep rough lipopolysaccharide. J Bacteriol. 1998;180(1):35–40.9422589
   PubMed Web of Science ®Google Scholar
• Linkevicius M, Sandegren L, Andersson DI. Mechanisms and fitness costs of tigecycline resistance in Escherichia coli. J Antimicrob Chemother. 2013;68(12):2809–2819. doi:10.1093/jac/dkt26323843301
   PubMed Web of Science ®Google Scholar
• Burtnick MN, Woods DE. Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. Antimicrob Agents Chemother. 1999;43(11):2648–2656. doi:10.1128/AAC.43.11.264810543742
   PubMed Web of Science ®Google Scholar
• Jeon B, Muraoka W,A, Zhang Q. Roles of lipooligosaccharide and capsular polysaccharide in antimicrobial resistance and natural transformation of Campylobacter jejuni. J Antimicrob Chemother. 2009;63(3):462–468. doi:10.1093/jac/dkn52919147521
   PubMed Web of Science ®Google Scholar
• Vandana C, Logan SM, Harrison BA, et al. Characterization of a waaF mutant of Helicobacter pylori strain 26695 provides evidence that an extended lipopolysaccharide structure has a limited role in the invasion of gastric cancer cells. Biochem Cell Biol. 2007;85(5):582–590. doi:10.1139/O07-05617901900
   PubMed Web of Science ®Google Scholar
• Stead CM, Jinshi Z, Raetz CRH, Trent MS. Removal of the outer Kdo from Helicobacter pylori lipopolysaccharide and its impact on the bacterial surface. Mol Microbiol. 2010;78(4):837–852. doi:10.1111/j.1365-2958.2010.07304.x20659292
   PubMed Web of Science ®Google Scholar
• Khamri W, Moran AP, Worku ML, et al. Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D. Infect Immun. 2005;73(11):7677. doi:10.1128/IAI.73.11.7677-7686.200516239572
   PubMed Web of Science ®Google Scholar
• Osato MS, Reddy R, Reddy SG, Penland RL, Graham DY. Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori. Int J Antimicrob Agents. 2001;17(1):39–44. doi:10.1016/S0924-8579(00)00320-411137647
   PubMed Web of Science ®Google Scholar
• Geng X, Li W, Chen Z, et al. Bifunctional enzyme SpoT is involved in the clarithromycin tolerance of Helicobacter pylori by up-regulating the transporters HP0939, HP1017, HP0497, and HP0471. Antimicrob Agents Chemother. 2017;61(5):AAC.02011–02016. doi:10.1128/AAC.02011-16
   Web of Science ®Google Scholar
• Giraud E, Cloeckaert A, Kerboeuf D, Chaslus-Dancla E. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium. Antimicrob Agents Chemother. 2000;44(5):1223–1228. doi:10.1128/AAC.44.5.1223-1228.200010770755
   PubMed Web of Science ®Google Scholar
• Mollison LC, Stingemore N, Wake RA, Cullen DJ, Mcgechie DB. Antibiotic resistance in Helicobacter pylori. Med J Aust. 2000;173(10):521–523. doi:10.5694/mja2.2000.173.issue-1011194734
   PubMed Web of Science ®Google Scholar
• Lee JW, Kim N, Kim JM, et al. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter. 2013;18(3):206–214. doi:10.1111/hel.2013.18.issue-323241101
   PubMed Web of Science ®Google Scholar
• Shiota S, Reddy R, Alsarraj A, El-Serag HB, Graham DY. Antibiotic resistance of helicobacter pylori among male United States veterans. Clin Gastroenterol Hepatol. 2015;13(9):1616–1624. doi:10.1016/j.cgh.2015.02.00525681693
   PubMed Web of Science ®Google Scholar
• Kocazeybek B, Tokman HB. Prevalence of primary antimicrobial resistance of H. pylori in Turkey: a systematic review. Helicobacter. 2016;21(4):251–260. doi:10.1111/hel.2016.21.issue-426395982
   PubMed Web of Science ®Google Scholar
• Schnaitman CA, Klena JD. Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol Rev. 1993;57(3):655.7504166
   PubMedGoogle Scholar
• Rodrigues L, Viveiros M, Aínsa JA. Measuring efflux and permeability in mycobacteria. Methods Mol Biol. 2015;1285:227–239.25779319
   PubMedGoogle Scholar